AstraZeneca.
British-Swedish pharmaceutical company
- Reports this week
- 1
- Active events
- 5
- Connections
- 795
What's happening
Active this week
-
Analyst reports are driving stock market sentiment for Ballard Power Systems, AstraZeneca, Amgen, and Amazon.Some support1 report
-
Dan Janiak joined OncoC4 as Chief Business Officer, having previously served at AstraZeneca.Some support2 reports
-
AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.Some support3 reports
-
Summit Therapeutics and AstraZeneca announced a partnership on July 4, 2025, to collaborate on lung cancer drug development.Some support4 reports
-
AstraZeneca formed a partnership with Daiichi Sankyo regarding Enhertu, and also established a profit-sharing deal with Merck for Lynparza.Some support4 reports1 development inside
Earlier this month
-
Shell overtook HSBC as the most valuable company, while AstraZeneca and Unilever are noted as global peers.Some support1 report
-
Mario Lopez promoted AstraZeneca's cancer testing campaign, while Dennis Haskins was noted for treating young stars with respect.Some support1 report
-
European stock markets showed mixed performance on October 30, with some sectors rising while tech faced sell-off concerns.Some support1 report
-
AstraZeneca listed shares on the New York Stock Exchange to attract investors.Some support1 report
-
AstraZeneca sought a mega-merger with a US rival, adding a specific development to the ongoing talks with Bristol-Myers Squibb.Well supported4 reports
-
Companies like BAE Systems, GSK, AstraZeneca, and HSBC are benefiting from geopolitical tensions, market recoveries, and strong market conditions in Europe.Well supported3 reports5 developments inside
-
Biopharma leaders from major companies gathered in Copenhagen to discuss commercial strategies and AI utilization.Some support1 report
-
AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.Some support1 report
-
Geopolitical instability in the Middle East has led to significant corporate fallout, including the cancellation of Flutter's London Stock Exchange listing and AstraZeneca considering a move to the US market.Some support2 reports
-
AstraZeneca is relocating its registered office from Karnataka to Bengaluru, citing proximity to policy and financial ecosystems.Some support1 report
-
Replimune Group received FDA accelerated approval, and Mestag Therapeutics appointed new board members, including Victor Sandor and Philip Astley-Sparke.Some support1 report
-
Oracle Corporation and AstraZeneca announced a collaboration to accelerate clinical research.Some support2 reports
-
Collaboration advances digital pathology in the Philippines involving AstraZeneca.Some support1 report
-
AstraZeneca plans a $2B facility in Tuas, Singapore, while President Shanmugaratnam conducts a state visit to Sweden.Some support1 report
-
A joint venture involving AstraZeneca and Ericsson, supported by Sweden, was formed to launch a Sferical AI supercomputer.Some support2 reports
-
American Cancer Society and AstraZeneca founded BCAM through a partnership between the two organizations.Some support1 report
-
A citizen-led inquiry has begun scrutinizing vaccine injury accountability and high rejection rates in compensation schemes involving AstraZeneca.Some support1 report1 development inside
-
AstraZeneca presented Phase III data for efzimfotase alfa at the American Society for Bone and Mineral Research annual meeting.Some support1 report
-
Jeff Farrow, who previously worked at companies involved in AstraZeneca and Horizon acquisitions, will serve on an Audit Committee.Some support1 report
-
AstraZeneca and Teva Pharmaceutical Industries Limited are being compared as large-cap healthcare companies regarding their revenue and earnings.Some support1 report
-
Biofrontera and AstraZeneca are being compared as healthcare companies for investment.Some support1 report
-
Jefferies Financial Group provided analyst ratings for AstraZeneca stock on June 20, 2026.Well supported7 reports
-
A partnership involving AstraZeneca and UNICEF addresses lung health and air pollution challenges in Thailand.Some support1 report
-
In March 2021, the United States loaned vaccine doses to both Mexico and Canada.Some support1 report
-
Roche terminated Ionis's Huntington's drug program, leading to market scrutiny and investment decisions for all involved pharmaceutical companies.Some support1 report
-
Aetna and AstraZeneca were both accused of denying coverage on October 9, 2026.Some support1 report
One to three months ago
-
Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.Some support1 report
-
AstraZeneca is investing in its US footprint to reach revenue goals and addressing a center opening on LinkedIn.Some support1 report
-
AstraZeneca and Tarsus Pharmaceuticals, Inc. are two healthcare companies that are currently competing for investment.Some support1 report
-
Dr Koh's professional background includes senior roles at GSK and AstraZeneca, and he is an Honorary Consultant in the NHS.Some support2 reports
-
AstraZeneca and Tvardi Therapeutics are being compared as healthcare companies.Some support1 report
-
AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Some support3 reports
-
Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Well supported4 reports12 developments inside
-
AstraZeneca, AMPATH, and Lancet Laboratories launched the Helix Project in South Africa for advanced genomic testing.Some support1 report
-
AstraZeneca supplies HVO to EcoCeres for manufacturing backup power.Some support1 report
-
Collaboration between IONQ, AstraZeneca, and Amazon demonstrates quantum-accelerated chemistry workflow using AWS infrastructure.Well supported3 reports1 development inside
-
Nvidia, IonQ, AstraZeneca, and AWS are partnering to demonstrate advanced computing workflows using a standard CPU.Some support1 report
-
Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.Some support1 report
-
Both the Netherlands and AstraZeneca were discussed as potential undervalued international investments.Some support1 report
-
Multiple major pharmaceutical companies were identified as industry peers for growth during a capital markets day.Some support1 report1 development inside
-
AbbVie, AstraZeneca, and Bristol-Myers Squibb collaborated on the AISB Bind AI initiative.Some support2 reports
-
The NHS in England has cleared Enhertu for use, strengthening its access and availability.Some support2 reports
-
AstraZeneca is supporting a food access initiative taking place in Queens.Some support1 report
-
Oklahoma State Law seeks to expand patient access to discounted drugs and faces lawsuits challenging the 340B program scope.Some support2 reports
-
Ionis Pharmaceuticals is seeking FDA approval for its treatments for Alexander disease, including Tryngolza, and has formed new partnerships with AstraZeneca and Hoffmann-La Roche.Some support2 reports1 development inside
-
Unpaid bills totaling R1bn are causing service suspensions in the Eastern Cape, affecting operations of AstraZeneca and Sandoz.Some support1 report
-
Tempus AI has named AstraZeneca as a customer, and Morgan Stanley boosted its revenue outlook.Some support2 reports
-
Analysts are monitoring the performance and pipeline risks of AstraZeneca, following concurrent stake purchases and increased holdings by Bank of America.Some support1 report1 development inside
-
AstraZeneca announced a major €26 billion investment in Wuxi, China, while simultaneously facing an underperform rating and tracking global oil prices.Some support1 report
-
AstraZeneca is supplying a nasal spray vaccine to Ireland.Some support1 report
-
A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.Some support1 report
-
Amit Shah oversaw anti-terror operations in Jammu and Kashmir, while simultaneously, an investment upgraded production bases in Wuxi.Some support1 report
-
Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.Some support3 reports4 developments inside
-
AstraZeneca's drug was tested in collaboration with Pfizer's drug.Some support1 report
-
AstraZeneca is facing market pressure following a clinical trial failure, leading to a decline in its stock value.Some support1 report1 development inside
No events began in the chosen period. Widen it, or reset.
What's reaching AstraZeneca
Events traced to AstraZeneca, step by step, newest first- New GSK drug could increase competitive pressure on AstraZenecaGSK's new hepatitis B drug may increase competitive pressure on AstraZeneca.Possible
- Pfizer's vaccine deal talks may shift biopharma market dynamics for AstraZenecaPfizer's vaccine deal talks may shift biopharma market dynamics for AstraZenecaPossible
- Moderna and Merck's vaccine success could intensify competition for AstraZenecaNew mRNA cancer vaccine results may intensify competition for AstraZeneca in oncologyPossible
- AbbVie's new immunology drug may increase pressure on AstraZenecaAbbVie's new immunology drug may increase pressure on AstraZenecaPossible
- AbbVie's pipeline expansion may increase competitive pressure on AstraZenecaAbbVie's new pipeline growth may increase competitive pressure on AstraZenecaPossible
- Akeso's US trial expansion could challenge AstraZeneca's market positionAkeso's US trial expansion could challenge AstraZeneca's market positionPossible
See all 11 explainers
- New therapies from AbbVie and BMS could challenge AstraZeneca's market positionNew approvals by competitors may increase competitive pressure on AstraZeneca.Possible
- AstraZeneca may expand clinical trial capabilities across IndiaAstraZeneca may expand its global clinical trial footprint and market access in IndiaPossible
- Competitors' rapid biologic advances may challenge AstraZeneca's market positionIncreased investment in biologics may intensify competitive pressure on AstraZenecaPossible
- AstraZeneca may face pressure to accelerate Lyme disease researchAstraZeneca may face pressure to accelerate Lyme disease researchPossible
- AstraZeneca stock dips amid EU approval news and market uncertaintyAstraZeneca stock fell 0.32% despite Enhertu receiving EU approval recommendation.Reported
Explainers that pass through AstraZeneca
AstraZeneca is a step on the way to someone elseAround AstraZeneca this week
News at the entities that move AstraZeneca most-
FDA StructuralThe FDA approved Miplyffa for the treatment of Niemann-Pick disease.Moves AstraZeneca
-
London Stock Exchange StructuralRio Tinto plc applied to list its shares on the London Stock Exchange.Moves AstraZeneca
-
Bristol-Myers Squibb TransactionalMajor pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.Moves AstraZeneca
-
Tempus OperationalTesla, Tempus, and Twist Bioscience are noted as companies operating in the precision medicine and biotech sectors.Moves AstraZeneca
-
Pfizer OperationalMedicus Pharma secured an ADC development deal with Pfizer and is advancing its SkinJect 005 study for FDA approval.Moves AstraZeneca
-
Compugen Ltd. StructuralCompugen Ltd. is researching and developing candidates in Europe and the United States.Moves AstraZeneca
Connections
The 40 strongest of 795, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Bristol-Myers Squibb Transactional
The two pharmaceutical companies are engaged in high-stakes, rumored merger talks regarding a potential combined entity valued at approximately $400 billion.
-
Daiichi Sankyo Structural
The companies are engaged in a deep, ongoing partnership for the joint development and commercialization of advanced cancer treatments, including Enhertu and Datroway.
-
FDA Structural
FDA formally regulates AstraZeneca's drug development, requiring designations, approvals, and reviews for market access.
-
FibroGen (United States) Transactional
AstraZeneca acquired FibroGen China and its assets through a series of sales and acquisitions.
-
London Stock Exchange Structural
AstraZeneca is formally listed on the London Stock Exchange, making the exchange critical for its valuation and market operations.
-
Pascal Soriot Structural
Pascal Soriot holds the executive leadership role as Chief Executive Officer of AstraZeneca.
-
Albemarle County Structural
AstraZeneca is establishing a major manufacturing campus in Albemarle County with a secured investment of $4.5 billion.
-
Tempus Operational
Tempus and AstraZeneca are engaged in a partnership to jointly develop an oncology foundation model, supported by a $200M data licensing deal.
Show all 40 connections
-
Pfizer Operational
Pfizer and AstraZeneca are active competitors in major biopharma markets, including oncology and functional dyspepsia.
-
Compugen Ltd. Structural
Compugen licenses technology and antibodies to AstraZeneca, enabling the development of the drug Rilvegostomig.
-
Eli Lilly and Company Operational
Eli Lilly and AstraZeneca are active competitors in the pharmaceutical market, vying for market share in oncology and obesity.
-
AbbVie Operational
AbbVie and AstraZeneca are direct competitors in oncology and dyslipidemia, while also engaging in strategic collaborations, such as AI initiatives.
-
Ionis Pharmaceuticals Transactional
The companies formed a joint development partnership for the Wainua gene-silencing drug candidate, which ultimately failed in late-stage clinical trials.
-
Daiichi Sankyo (United Kingdom) Operational
AstraZeneca and Daiichi Sankyo maintain a formal partnership and licensing agreement for the drug Enhertu.
-
Morgan Stanley Operational
Morgan Stanley provides financial ratings, stock advice, and investment banking services for AstraZeneca.
-
Frank Sciurba Structural
Frank Sciurba serves as the Chief Investigator for AstraZeneca's LUNA programme, linking his expertise to the company's research announcements.
-
GSK Operational
GSK and AstraZeneca are direct competitors in the pharmaceutical market, facing rivalry in oncology and respiratory sectors.
-
Royal Bank of Canada Structural
Royal Bank of Canada is increasing its financial stake and providing investment coverage on AstraZeneca stock.
-
Hutchison MediPharma Limited Structural
AstraZeneca and Hutchison MediPharma are engaged in a formal joint development and commercialization partnership for the drug savolitinib.
-
Merck Operational
AstraZeneca and Merck actively compete in the oncology space while maintaining a strategic partnership involving co-marketing and profit-sharing deals.
-
Daiichi Operational
AstraZeneca and Daiichi are engaged in a formal partnership for joint drug development and marketing.
-
Summit Therapeutics Operational
Summit Therapeutics and AstraZeneca maintain a strategic collaboration focused on developing oncology treatments and expanding drug reach.
-
Fusion Pharmaceuticals Structural
Fusion Pharmaceuticals was acquired by AstraZeneca in 2024 for approximately US$2 billion.
-
European Medicines Agency Structural
The European Medicines Agency regulates and reviews AstraZeneca's pharmaceutical products for market approval.
-
Union Investment Structural
Union Investment is a current shareholder in AstraZeneca, creating a dependency structure.
-
Alnylam Pharmaceuticals Operational
The companies are direct competitors in the ATTR-CM indication while also maintaining a formal partnership on drug development.
-
Hoffmann-La Roche Operational
Hoffmann-La Roche and AstraZeneca are direct competitors in the pharmaceutical market, facing rivalry and shared market pressures.
-
American Society of Clinical Oncology Operational
AstraZeneca utilizes the ASCO Annual Meeting as a platform for presenting clinical trial results and engaging with the oncology scientific community.
-
Amundi Transactional
Amundi repeatedly increased its financial holdings and stake in AstraZeneca shares.
-
Sanofi Operational
Sanofi and AstraZeneca are actively collaborating on the production and scaling of the drug Beyfortus.
-
Johnson & Johnson Operational
Johnson & Johnson and AstraZeneca are major pharmaceutical companies engaged in direct competition within the oncology and immunology markets.
-
Amgen Operational
Amgen and AstraZeneca maintain a relationship characterized by active market competition alongside formal collaborative drug development and joint trials.
-
IONQ Operational
IONQ and AstraZeneca maintain an active partnership focused on leveraging quantum computing for accelerating drug discovery and computational chemistry workflows.
-
Biogen Operational
The two companies are actively competing in the market, facing pressure to meet ambitious revenue targets.
-
SEC Structural
AstraZeneca is subject to financial reporting and regulatory oversight by the SEC.
-
CSPC Pharmaceutical Group Operational
AstraZeneca and CSPC are actively collaborating on AI drug discovery and experimental treatments for chronic diseases, including kidney disease.
-
Sophia Genetics Operational
AstraZeneca and Sophia Genetics have formed a multi-year partnership to leverage AI for breast cancer therapies.
-
Novo Nordisk Operational
The two companies are direct, active competitors, specifically challenging each other in the obesity drug market.
-
Court of Justice of the European Union Structural
AstraZeneca operates as a company subject to the jurisdiction, rulings, and oversight of the Court of Justice of the European Union.
-
Edge Structural
Edge was employed as a scientist at AstraZeneca.
History
Events by the month they beganNovember 2026
3 events- Analyst reports are driving stock market sentiment for Ballard Power Systems, AstraZeneca, Amgen, and Amazon.
- Dan Janiak joined OncoC4 as Chief Business Officer, having previously served at AstraZeneca.
- Shell overtook HSBC as the most valuable company, while AstraZeneca and Unilever are noted as global peers.
October 2026
25 events- AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.
- Mario Lopez promoted AstraZeneca's cancer testing campaign, while Dennis Haskins was noted for treating young stars with respect.
- European stock markets showed mixed performance on October 30, with some sectors rising while tech faced sell-off concerns.
- AstraZeneca listed shares on the New York Stock Exchange to attract investors.
- Biopharma leaders from major companies gathered in Copenhagen to discuss commercial strategies and AI utilization.
- AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
- AstraZeneca is relocating its registered office from Karnataka to Bengaluru, citing proximity to policy and financial ecosystems.
- Replimune Group received FDA accelerated approval, and Mestag Therapeutics appointed new board members, including Victor Sandor and Philip Astley-Sparke.
- Oracle Corporation and AstraZeneca announced a collaboration to accelerate clinical research.
- Collaboration advances digital pathology in the Philippines involving AstraZeneca.
- AstraZeneca plans a $2B facility in Tuas, Singapore, while President Shanmugaratnam conducts a state visit to Sweden.
- American Cancer Society and AstraZeneca founded BCAM through a partnership between the two organizations.
- AstraZeneca presented Phase III data for efzimfotase alfa at the American Society for Bone and Mineral Research annual meeting.
- Jeff Farrow, who previously worked at companies involved in AstraZeneca and Horizon acquisitions, will serve on an Audit Committee.
- AstraZeneca and Teva Pharmaceutical Industries Limited are being compared as large-cap healthcare companies regarding their revenue and earnings.
- Biofrontera and AstraZeneca are being compared as healthcare companies for investment.
- A partnership involving AstraZeneca and UNICEF addresses lung health and air pollution challenges in Thailand.
- In March 2021, the United States loaned vaccine doses to both Mexico and Canada.
- Roche terminated Ionis's Huntington's drug program, leading to market scrutiny and investment decisions for all involved pharmaceutical companies.
- Aetna and AstraZeneca were both accused of denying coverage on October 9, 2026.
- Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.
- AstraZeneca is investing in its US footprint to reach revenue goals and addressing a center opening on LinkedIn.
- AstraZeneca and Tarsus Pharmaceuticals, Inc. are two healthcare companies that are currently competing for investment.
- Dr Koh's professional background includes senior roles at GSK and AstraZeneca, and he is an Honorary Consultant in the NHS.
- AstraZeneca and Tvardi Therapeutics are being compared as healthcare companies.
September 2026
19 events- Geopolitical instability in the Middle East has led to significant corporate fallout, including the cancellation of Flutter's London Stock Exchange listing and AstraZeneca considering a move to the US market.
- AstraZeneca, AMPATH, and Lancet Laboratories launched the Helix Project in South Africa for advanced genomic testing.
- AstraZeneca supplies HVO to EcoCeres for manufacturing backup power.
- Nvidia, IonQ, AstraZeneca, and AWS are partnering to demonstrate advanced computing workflows using a standard CPU.
- Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.
- Both the Netherlands and AstraZeneca were discussed as potential undervalued international investments.
- Multiple major pharmaceutical companies were identified as industry peers for growth during a capital markets day.
- AbbVie, AstraZeneca, and Bristol-Myers Squibb collaborated on the AISB Bind AI initiative.
- The NHS in England has cleared Enhertu for use, strengthening its access and availability.
- AstraZeneca is supporting a food access initiative taking place in Queens.
- Oklahoma State Law seeks to expand patient access to discounted drugs and faces lawsuits challenging the 340B program scope.
- Ionis Pharmaceuticals is seeking FDA approval for its treatments for Alexander disease, including Tryngolza, and has formed new partnerships with AstraZeneca and Hoffmann-La Roche.
- Unpaid bills totaling R1bn are causing service suspensions in the Eastern Cape, affecting operations of AstraZeneca and Sandoz.
- Tempus AI has named AstraZeneca as a customer, and Morgan Stanley boosted its revenue outlook.
- AstraZeneca announced a major €26 billion investment in Wuxi, China, while simultaneously facing an underperform rating and tracking global oil prices.
- AstraZeneca is supplying a nasal spray vaccine to Ireland.
- A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.
- Amit Shah oversaw anti-terror operations in Jammu and Kashmir, while simultaneously, an investment upgraded production bases in Wuxi.
- AstraZeneca's drug was tested in collaboration with Pfizer's drug.
Show 3 earlier months
August 2026
2 eventsJuly 2026
2 eventsJune 2026
9 events- Summit Therapeutics and AstraZeneca announced a partnership on July 4, 2025, to collaborate on lung cancer drug development.
- AstraZeneca formed a partnership with Daiichi Sankyo regarding Enhertu, and also established a profit-sharing deal with Merck for Lynparza.
- Companies like BAE Systems, GSK, AstraZeneca, and HSBC are benefiting from geopolitical tensions, market recoveries, and strong market conditions in Europe.
- A joint venture involving AstraZeneca and Ericsson, supported by Sweden, was formed to launch a Sferical AI supercomputer.
- A citizen-led inquiry has begun scrutinizing vaccine injury accountability and high rejection rates in compensation schemes involving AstraZeneca.
- Jefferies Financial Group provided analyst ratings for AstraZeneca stock on June 20, 2026.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Collaboration between IONQ, AstraZeneca, and Amazon demonstrates quantum-accelerated chemistry workflow using AWS infrastructure.
- Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.